Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Auxilium
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Auxilium Biotechnologies is a company focused on regenerative medicine and medical devices, utilizing 3D bioprinting technology. They successfully deployed the first 3D bioprinter on the International Space Station (ISS) to print implantable medical devices. Their lead product, NeuroSpan Bridge, is currently in a pivotal clinical trial for peripheral nerve regeneration.
- Therapeutic areas
- Neurology
- Modalities
- DeviceBioprinted implant
- Industry
- Implantable Medical Devices
02
Partnerships
NASA (InSpace Production Applications program funding)Multiple research labs (discussions for future ISS bioprinting projects)
Beyond the preview
Go deeper on Auxilium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Auxilium.